Board Meeting12 May 2026, 05:31 pm
Neuland Labs Appoints Dr. Mauricio Futran as Additional Director
AI Summary
Neuland Laboratories Ltd has appointed Dr. Mauricio Futran as an Additional Director, categorized as Non-Executive Non-Independent, effective May 12, 2026. This appointment is based on the recommendation of the Nomination and Remuneration Committee and is subject to shareholder approval at the upcoming AGM. The board also approved the audited financial results for the year ended March 31, 2026, recommended a final dividend of ₹34 per share, approved convening the AGM on August 4, 2026, and approved capacity enhancement at Unit 1.
Key Highlights
- Dr. Mauricio Futran appointed as Non-Executive Non-Independent Additional Director.
- Final dividend of ₹34 per share recommended for FY26.
- 42nd AGM approved for August 4, 2026; record date fixed as July 24, 2026.
- Capacity expansion of 120.5 KL approved at Unit 1 with ₹143.4 crore investment.
- Audited financial results for FY26 approved with unmodified opinion from auditors.
Price Impact
More from NEULANDLAB